🇺🇸 FDA

Company profile · Sponsor

Corbus

Corbus Pharmaceuticals Holdings

CRBP · NYSE pharma NORWOOD, MA, USA
Pipeline
11
Drugs
0
Patents
6

Quick answer

Corbus (CRBP) is a pharma company. headquartered in NORWOOD, MA, USA. listed on NYSE. NovaPharmaNews links 11 pipeline programs, 0 drugs, and 6 patents to this profile..

Company facts

Ticker CRBP
Exchange NYSE
Company type pharma
Headquarters NORWOOD, MA, USA
SEC CIK 0001595097

Pipeline (11)

Search pipeline →

  1. Lenabasum 20 mg

    Corbus

    Dermatomyositis

    phase 3 small molecule completed

    1 trial

  2. Lenabasum 5 mg

    Corbus

    Diffuse Cutaneous Systemic Sclerosis

    phase 3 small molecule terminated

    1 trial

  3. A Clinical Trial for Patients with Advanced Cancers

    Corbus

    Advanced Solid tumour

    phase 2 other active

    1 trial

  4. CRB-601 monoclonal antibody

    Corbus

    Solid Tumor

    phase 2 small molecule active

    1 trial

  5. CRB-701

    Corbus

    Solid Tumor, Adult

    phase 2 small molecule active

    1 trial

  6. JBT-101

    Corbus

    Diffuse Cutaneous Systemic Sclerosis

    phase 2 small molecule terminated

    1 trial

  7. JBT-101

    Corbus

    Systemic Lupus Erythematosus

    phase 2 small molecule completed

    1 trial

  8. JBT-101

    Corbus

    Dermatomyositis

    phase 2 small molecule terminated

    1 trial

  9. JBT-101 (lenabasum)

    Corbus

    Cystic Fibrosis

    phase 2 small molecule completed

    1 trial

  10. Lenabasum 20 mg

    Corbus

    Cystic Fibrosis

    phase 2 small molecule completed

    1 trial

  11. CRB-913

    Corbus

    Obese But Otherwise Healthy Participants

    phase 1 small molecule active

    1 trial

Patents (6)

Search patents →

  1. US 11052066

    Ultrapure tetrahydrocannabinol-11-oic acids

    Expires Mon Jul 01 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 10369131

    Ultrapure tetrahydrocannabinol-11-oic acids

    Expires Mon Aug 01 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 10154986

    Ultrapure tetrahydrocannabinol-11-oic acids

    Expires Mon Dec 13 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 10085964

    Ultrapure tetrahydrocannabinol-11-oic acids

    Expires Mon Sep 27 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 9820964

    Ultrapure tetrahydrocannabinol-11-oic acids

    Expires Mon Nov 16 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. US 9801849

    Ultrapure tetrahydrocannabinol-11-oic acids

    Expires Mon Oct 26 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

What is Corbus?

Corbus (CRBP) is a pharma company. headquartered in NORWOOD, MA, USA. listed on NYSE. NovaPharmaNews links 11 pipeline programs, 0 drugs, and 6 patents to this profile..

What pipeline programs does Corbus sponsor?

We track 11 ClinicalTrials.gov-linked programs for Corbus, including Lenabasum 20 mg and 10 more. Open each program for phase, modality, NCT IDs, and indication details.

Where does Corbus company data come from?

Profiles combine SEC EDGAR (CIK/ticker), ClinicalTrials.gov sponsor links, FDA drug records, and USPTO patent metadata. See our data sources page. This profile is for professional reference, not investment advice.